Aspirin inhibits the formation of pentosidine, a cross-linking advanced glycation end product, in collagen.

by P Urios, a-M Grigorova-Borsos, M Sternberg
Diabetes research and clinical practice ()


Aspirin showed an inhibitory effect on the formation of pentosidine, a cross-linking advanced glycation endproduct, in collagen incubated with glucose in vitro. IC(50) was evaluated at 10mmol/l. Aspirin might act by metallic ion chelating (as did EDTA and DTPA) and by oxygen radical scavenging. Since aspirin was reported to inhibit retinopathy in diabetic dogs, it could act partly by inhibiting advanced glycation endproduct accumulation in long-lived proteins like collagens.

Cite this document (BETA)

Readership Statistics

8 Readers on Mendeley
by Discipline
by Academic Status
50% Ph.D. Student
13% Other Professional
13% Researcher (at an Academic Institution)

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in